Both in Pharmaceuticals
Apnimed vs ArriVent BioPharma
Over the past year APMD returned −37.5% and AVBP returned −48.7%; their daily moves had a correlation of 0.37.
APMD −37.5% AVBP −48.7%Growth of $1, one year, split-adjusted
| Metric | APMD | AVBP |
|---|---|---|
| Price | $16.40 | $14.87 |
| Market cap | $682.7M | $733.2M |
| Today | −5.42% | −6.77% |
| 1 month | −27.2% | −48.6% |
| 6 months | — | −50.4% |
| Year to date | — | −26.1% |
| 1 year | — | −20.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $373.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 153.2% |
| Short % of float | 10.1% | 20.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).